[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-328868-105":59,"doc-detail-328868-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","core-training-and-implementation-team-ucla-integrated-substance-abuse-programs-learning-objectives","Core Training and Implementation Team UCLA Integrated Substance Abuse Programs - Learning Objectives","","8/28/2025 training materials for the UCLA Integrated Substance Abuse Programs Core Training and Implementation Team. The content identifies team and partner roles and outlines learning objectives focused on contingent management (CM) for treating stimulant use disorder. It explains drivers of drug poisoning deaths shifting from opioids to stimulants, describes stimulant drug types and brain effects, and presents behavioral principles of CM using positive reinforcement. It also covers evidence expectations, required implementation elements for the Recovery Incentives Program, and outreach approaches to recruit participants into California’s Contingency Management Benefit.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/core-training-and-implementation-team-ucla-integrated-substance-abuse-programs-learning-objectives/328868/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/core-training-and-implementation-team-ucla-integrated-substance-abuse-programs-learning-objectives/328868.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What learning objectives guide this training on CM for stimulant use disorder?","Question",{"text":112,"@type":113},"The objectives require describing at least three forms of empirical evidence supporting CM, identifying four required elements for implementing the Recovery Incentives Program, and specifying at least two outreach forms for recruiting members into the program.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does CM use positive reinforcement to support abstinence?",{"text":117,"@type":113},"CM provides tangible incentives such as gift cards only when a urine drug test is negative for stimulants. Incentives escalate over time when stimulant abstinence is consistently achieved.",{"name":119,"@type":110,"acceptedAnswer":120},"What characteristics define effective positive reinforcement in CM?",{"text":121,"@type":113},"Effective reinforcement is clearly defined and achievable, includes a desirable tangible incentive, uses timely pairing between behavior and recovery incentives, and is contingent and consistent with frequent observation and rewards.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},328868,1790494363,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","8/28/2025  \n1  \nCore Training and Implementation Team UCLA Integrated Substance Abuse Programs  \n􀂖Thomas E. Freese, PhD, and Beth A. Rutkowski, MPH, Co-PIs  \n􀂖Samantha Santamaria, LCSW, Rosana Trivino-Perez, LCSW, and Ricardo Garcia, BA, Core CM Trainers  \n􀂖James Peck, PsyD, Clinical Trainer (retired)  \n􀂖Caitlin Thompson, MPP, MPH, Project Director, Training and Readiness  \n􀂖Adrienne Datrice, Project Director, Fidelity and Implementation Coaching  \n􀂖Julian Simmons, Training Coordinator  \n􀂖Sara Parent, ND, and Michael McDonell, PhD (WSU PRISM)  \n2  \nCalifornia Department of Health Care Services  \n􀂖 Tyler Sadwith, Deputy Director, Behavioral Health  \n􀂖 Anton Nigusse-Bland, MD Clinical Consultant  \n􀂖 Alexandria Simpson, Chief, Behavioral Health Community & Crisis Care Programs  \n􀂖 Melissa Barry, ND, MPH, Health Program Specialist  \n􀂖 Ka Ramirez, Health Program Specialist  \n􀂖 Crystal Slaton, MPH, Associate Governmental Program Analyst  \nAdditional Core Training and Implementation Team Members  \n􀂖Michael McDonell, PhD, and Sara Parent, ND – Washington State University  \n􀂖Sara Becker, PhD – Brown University and New England ATTC  \n3  \n8/28/2025  \nQ2i Team Member  \n􀂖 Dominic Trupiano  \n􀂖 Jorge Arrieta  \nManatt Health Strategies Team Members  \n􀂖 Kier Wallis  \n􀂖Zoe Barnard  \n􀂖Gina Rogari  \n4  \nLearning Objectives:  \n1. Describe at least three (3) forms of empirical evidence to support CM as an intervention for treating stimulant use disorder.  \n2. Identify the four (4) required elements involved in effectively implementing the Recovery Incentives Program.  \n3. Specify at least two (2) forms of outreach for recruiting members into the Recovery Incentives Program: California’s Contingency Management Benefit.  \n5  \n6  \n8/28/2025  \n7  \n8  \nDrivers of Drug Poisoning Deaths Evolve from Opioids to Stimulants  \nSOURCE: Hedegaard & Spencer, 2021 9  \n9  \n8/28/2025  \n10  \nSource: CDC, 2023  \n10  \n2000 2002 2004 2006 2008 2010 2012 2014 2016 2018 2020  \nSOURCE: Drug Enforcement Administration, 2021 11  \n11  \n12  \n4  \n8/28/2025  \n13  \n14  \n15  \n8/28/2025  \n16  \nStimulant Drugs and Their Effects on the Brain  \n17  \nTypes of Stimulant Drugs  \n􀂖 Methamphetamine  \n􀂖Powder: inhaled, smoked, injected  \n􀂖 Crystal/Ice: smoked  \n􀂖Tablets: orally, crushed and inhaled, smoked, injected  \n􀂖 Amphetamine  \n􀂖 Powder, Tablets, Liquid: orally, injected, smoked  \n􀂖Cocaine  \n􀂖Powder: inhaled, smoked, injected  \n􀂖 “Crack”(smoked)  \n18  \n18  \n8/28/2025  \nNatural Rewards Elevate Dopamine Levels  \nSOURCES: Bassareo & DiChiara, 1999; Fiorino & Phillips, 1997 19  \n19  \n0 1 2 3hr  \nTime After Methamphetamine  \nSources: Shoblock and Sullivan; Di Chiara and Imperato  \n0   \nTime After Cocaine  \n20  \n20  \nSubstance Use Does Several Things...  \n􀂖Produces positive feelings (positive reinforcement)  \n􀂖Removes unpleasant feelings (negative reinforcement)  \n􀂖Results in a loss of many other reinforcers (e.g., employment, family, friends)  \nConclusion: Substances are highly reinforcing and can hijack the reward pathways of the brain.  \n21  \n21  \n7  \n8/28/2025  \n22  \nThe Behavioral Principles of CM  \n23  \n24  \n8  \n8/28/2025  \nCM Uses Positive Reinforcement to Help People  \nChoose Abstinence Over Substance Use  \n􀂖CM uses tangible incentives (i.e., gift cards)  \n􀂖 Incentives (i.e., gift cards) are only provided when a UDT is negative for stimulants (e.g., cocaine, amphetamine and methamphetamine)  \n􀂖Rewards (i.e., gift cards) increase, or escalate, over time when the stimulant abstinence is consistently achieved  \n25  \n25  \nCharacteristics of Effective Positive Reinforcement  \n􀂖 Clearly defined and achievable behavior  \n􀂖Desirable and tangible incentive  \n􀂖Timely pairing of behavior and recovery incentive  \n􀂖 Contingent (incentives provided only when behavior is demonstrated)  \n􀂖Consistent (behavior is frequently observed and incentivized)  \n26  \n26  \nStudy – Influence of an Alternative Reinforcer on Human Cocaine Self-Administration  \n27  \nSOURCE: Higgins, Bickel, & Hughes, 1994  \n27  \n8","cbCaiaa1KtTR9ntw","https://ap.wps.com/l/cbCaiaa1KtTR9ntw","pdf",1295686,28,"English","# Core Training and Implementation Team\n## Learning Objectives\n# Drivers and Context\n## Drug Poisoning Deaths Shift Toward Stimulants\n# Stimulant Drugs and Brain Effects\n## Types of Stimulant Drugs\n# Behavioral Principles of CM\n## Natural Rewards and Dopamine\n## Substance Use Reinforcement Mechanisms\n## CM Uses Positive Reinforcement\n## Characteristics of Effective Positive Reinforcement\n# Practical Examples and Evidence\n## Everyday Examples of Positive Reinforcement\n## Evidence for CM as an Intervention for Stimulant Use","[{\"question\":\"What learning objectives guide this training on CM for stimulant use disorder?\",\"answer\":\"The objectives require describing at least three forms of empirical evidence supporting CM, identifying four required elements for implementing the Recovery Incentives Program, and specifying at least two outreach forms for recruiting members into the program.\"},{\"question\":\"How does CM use positive reinforcement to support abstinence?\",\"answer\":\"CM provides tangible incentives such as gift cards only when a urine drug test is negative for stimulants. Incentives escalate over time when stimulant abstinence is consistently achieved.\"},{\"question\":\"What characteristics define effective positive reinforcement in CM?\",\"answer\":\"Effective reinforcement is clearly defined and achievable, includes a desirable tangible incentive, uses timely pairing between behavior and recovery incentives, and is contingent and consistent with frequent observation and rewards.\"}]","Core Training and Implementation Team UCLA Integrated Substance Abuse Programs - Learning Objectives | PDF",1789981402,71]